My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Immunome, Inc. - Common Stock (NQ:IMNM)

23.05 +0.41 (+1.81%)

Streaming Delayed Price Updated: 3:19 PM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Immunome, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Why Immunome Stock Surged Today ↗

December 15, 2025

The oncology specialist's targeted therapies could improve thousands of lives.

Via The Motley Fool

Which stocks are gapping on Monday? ↗

December 15, 2025

In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Why Is IMNM Stock Rising Today? ↗

December 15, 2025

Immunome stock is on track to open at its highest levels in over 20 months, after the company reported positive topline results from its global Phase 3 RINGSIDE trial for a treatment targeting a type...

Via Stocktwits

Where Immunome Stands With Analysts ↗

September 22, 2025

Via Benzinga

This Crocs Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday ↗

September 22, 2025

Via Benzinga

Where Immunome Stands With Analysts ↗

September 05, 2025

Via Benzinga

Immunome Stock Rises After Craig-Hellum Initiates Coverage With $26 Price Target: Here’s Why The Analyst Sees An ‘Attractive Entry Point’ ↗

September 05, 2025

Via Stocktwits

This GATX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

September 22, 2025

Via Benzinga

This Netgear Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday ↗

August 22, 2025

Via Benzinga

Immunome (IMNM) Q2 Revenue Surges 382% ↗

August 06, 2025

Via The Motley Fool

These stocks are moving in today's after hours session ↗

June 30, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Analyst Expectations For Immunome's Future ↗

November 08, 2024

Via Benzinga

Evaluating Immunome: Insights From 4 Financial Analysts ↗

May 31, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 26, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 30, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

January 29, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

3 Small-Cap Stocks With Big Growth Potential

December 13, 2024

Small-cap companies may give investors more targeted exposure to the U.S. economy; these companies are three leaders in the space.

Via MarketBeat

Topics Economy

This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗

November 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 01, 2024

Via Benzinga

Immunome Stock Sees RS Rating Jump To 91 ↗

August 20, 2024

Immunome stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 88 to 91.

Via Investor's Business Daily

IMNM Stock Earnings: Immunome Misses EPS, Misses Revenue for Q2 2024 ↗

August 12, 2024

IMNM stock results show that Immunome missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks Insiders Are Buying ↗

May 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 21, 2024

Via Benzinga

IMNM Stock Earnings: Immunome Beats EPS, Misses Revenue for Q1 2024 ↗

May 14, 2024

IMNM stock results show that Immunome beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

IMNM Stock Earnings: Immunome Beats EPS, Beats Revenue for Q4 2023 ↗

March 28, 2024

IMNM stock results show that Immunome beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday? ↗

March 28, 2024

In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting some setbacks in market expectations regarding interest rate reductions.

Via Benzinga

Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday ↗

March 22, 2024

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

Via Benzinga

Topics Stocks

Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue? ↗

February 28, 2024

The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the highs of 2021. David Prince, professional trader at T3 Trading Group, joined...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.